RockStep Blog

Managing your in vivo operations through the COVID-19 outbreak

Safe social distancing is crucial to community survival in a pandemic outbreak. In order to avoid community spread of infection, many companies in the US and Europe are requiring all non-critical staff to work remotely. With the right tools in place, in vivo operations can run smoothly and still achieve the goals of safe social distancing.  RockStep’s Climb platform for in vivo study management and are perfectly suited for helping organizations move forward through this crisis. Read more.

Download this pdf to help you survive the COVID-19 outbreak.

RockStep’s in vivo Platform, Climb, helps a CRO deliver a better customer experience

CROs and their customers struggle with project management. Documents are emailed back and forth and the customer has limited visibility into the study execution and progress. CROs are delivering data to their customers in pdf files, spreadsheets, and share-folders.  Climb offers the perfect solution for the CRO.  In this use-case study, the RockStep team deploys Climb to solve the data delivery, study execution, and project management problem for an R&D provider.

Download the Climb / CRO Use Case Study

Evolution of User Experience for Life Sciences UX

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centers on the behaviors and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to percolate to other more complex sectors, such as the life sciences.  As the benefits of adoption of UX come to be realized, we see steady and strong growth in the R&D life sciences sector…  read more about this subject in this publication in Drug Discovery World.  RockStep’s Julie Morrison co-authored the paper with the Pistoia Alliance UXLS group.

in vivo Lab Informatics White Paper

Each year billions of dollars are wasted as drug developers struggle to effectively manage in vivo studies. Poor operations and data management slows progress and reduces data quality.  90% of all compounds that make it to Phase I clinical trials fail to gain FDA approval.  Improving in vivo study management can help speed drugs to market and get wrong drugs out of the pipeline faster. Learn about challenges faced in animal-lab research and how an effective SaaS informatics platforms can help bring order to chaos.

Download the white paper.

Implementing a Digital Transformation

What is the difference between digitized and digitalized?  Why should you consider implementing a digital transformation?  Is your organization even ready to implement a digital transformation?  Evidence suggests that successful digital transformations are speeding time to market for drug developers and reducing the costs of operations. Chuck Donnelly and Julie Morrison published a high level guide on how to get started.

Download the article.

Making Data Fly In-formation

Data should be treated as a first class asset. In fact, for the most part, data are the only output of our work. Data costs enormous amounts of time and money to generate and  analyze, and the never go bad. Data can be repurposed for research into other disease areas. And, as we prepare for the lab of the future, data will need to be harmonized and aggregated so that AI algorithms can help with analysis. 

However, most organization treat data as a side products that were created to generate reports and academic papers. The source data are put in share folders and often used only once. The source data itself are often fragmented and not harmonized and can never be reused because they are not annotated with standard vocabularies.  

Here is a 40 minute talk on this subject given by Julie Morrison and Chuck Donnelly. The talk was presented at the 2019 Lab Root/Lab Animal Sciences conference